Position in AZN
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$1,240,683
+$486,120 QoQ
Shares Held
6,543
+71.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#622
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Summit Global Investments holds $32,800,954 across 11 Drug Manufacturers - General names. AZN ranks #8 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
10,407 | $12,482,469 | |
| 2 | MRK |
Merck & Co., Inc.
|
52,039 | $6,687,011 | |
| 3 | ABBV |
AbbVie Inc.
|
11,572 | $2,911,978 | |
| 4 | JNJ |
Johnson & Johnson
|
9,808 | $2,490,937 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
11,712 | $1,479,694 | |
| 6 | PFE |
Pfizer Inc
|
60,517 | $1,457,249 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
23,680 | $1,364,441 | |
| 8 | AZN |
Astrazeneca PLC
This page
|
6,543 | $1,240,683 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,240,683 | 6,543 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $754,563 | 3,826 | Shares | Sole | 2026-05-07 | |
| No filing history on record for this holder in this stock. | ||||||